EyeMacular Regeneration
EyeMacular Regeneration is a startup headquartered in St. Paul, United States, founded in 2023. It has raised at least $2.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
EyeMacular Regeneration has raised at least $2.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
EyeMacular Regeneration sits inside the Minneapolis region R&D ecosystem in the Global R&D Labs Directory.
Other startups in St. Paul
Related
Questions and answers
What does EyeMacular Regeneration do?
EyeMacular Regeneration is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has EyeMacular Regeneration raised?
At least $2.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is EyeMacular Regeneration based?
EyeMacular Regeneration is headquartered in St. Paul, United States.
When was EyeMacular Regeneration founded?
EyeMacular Regeneration was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.